Here's the program of the 2014 World Transplant Congress,
Joint meeting ofAnd here's my part of the program...my working title is "Transplantation: One economist’s perspective," and I'll talk about how changes in the organization of transplantation have increased access to transplants, and how further changes might lead to further improvements.
Here's some background on the meeting:
"Recent progress in iPS cell research towards regenerative medicine
Professor Shinya Yamanaka, MD, PhD, is the Director of the Center for iPS Cell Research and Application (CiRA) at Kyoto University in Japan. In 2012, he was awarded the Nobel Prize in Physiology or Medicine for the discovery of reprogramming and converting mature, specialized cells into pluripotent cells, capable of developing into all tissues of the body.
During his State-of-the-Art address on Wednesday, July 30, Dr. Yamanaka will provide characteristics of induced pluripotent stem cells (iPSCs), which have the ability to proliferate and differentiate into multiple lineages. He will discuss technologies related to iPSC generation, in addition to improvements achieved in iPSC production in terms of both safety and efficiency. These iPSCs and subsequently differentiated target cells/ tissues would provide unprecedented opportunities in regenerative medicine, disease modelling, proof-of-concept studies in drug development, drug screening, and future personalized medicine."